Minimally Invasive Neurology: It is expected that the revenue in the first half of the year will increase by about 34% to 37% compared to the same period last year.
Minimally Invasive Brain Science announced that it is expected to achieve a revenue of 4 billion to 4.1 billion in the first half of the year, a year-on-year increase of about 34% to 37%. The revenue growth is mainly attributed to breakthroughs in overseas business, with an expected increase in revenue of about 70% to 90%; an increase in market share of intracranial atherosclerotic stenosis products; benefits of spring coil products from centralized procurement bids, accelerating the development of blank markets; and the accelerated hospital access and clinical use of multiple acute ischemic stroke and pathway products.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Minimally Invasive Neurology: It is expected that the revenue in the first half of the year will increase by about 34% to 37% compared to the same period last year.
Minimally Invasive Brain Science announced that it is expected to achieve a revenue of 4 billion to 4.1 billion in the first half of the year, a year-on-year increase of about 34% to 37%. The revenue growth is mainly attributed to breakthroughs in overseas business, with an expected increase in revenue of about 70% to 90%; an increase in market share of intracranial atherosclerotic stenosis products; benefits of spring coil products from centralized procurement bids, accelerating the development of blank markets; and the accelerated hospital access and clinical use of multiple acute ischemic stroke and pathway products.